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Introduction {#sec1}
============

Many viruses exploit direct cell-cell infection to replicate most efficiently. HIV-1 is no exception and has evolved to take advantage of the frequent interactions between immune cells in lymphoid tissue to disseminate at sites of T cell-T cell contact ([@bib18], [@bib29], [@bib45]). Indeed, cell-cell spread is the predominant mode of HIV-1 replication ([@bib15], [@bib20], [@bib25], [@bib49]) that ultimately leads to T cell depletion and the development of AIDS. HIV-1 manipulation of immune cell interactions in lymphoid tissue, where T cells are densely packed, allows for rapid HIV-1 spread and evasion of host defenses, including innate ([@bib21]) and adaptive immunity ([@bib24], [@bib28]) as well as antiretrovirals ([@bib2], [@bib46], [@bib52]). Importantly, ongoing viral replication likely prevents an HIV/AIDS cure. Cell-cell spread of HIV-1 occurs across virus-induced T cell-T cell contacts (virological synapses \[VSs\]; [@bib18]) and is a dynamic, calcium-dependent process that appears highly regulated ([@bib25], [@bib13]), culminating in polarized viral egress and rapid infection of neighboring cells. The molecular details of how HIV-1 co-opts the host cell machinery to drive maximally efficient spread between permissive T cells remains unclear. Moreover, whether cell-cell spread induces signals that potentiate viral replication has been little considered but has major implications for therapeutic and eradication strategies.

Phosphorylation-mediated signaling controls many cellular functions, including immune cell interactions and cellular responses to the environment and infection. Quantitative phosphoproteomics analysis by mass spectrometry (MS) allows for global, in-depth profiling of protein phosphorylation kinetics ([@bib34]). When coupled with functional analysis, such studies have helped define the pathways leading to T cell activation, differentiation, and gain of effector function, paving the way to understanding the molecular details of T cell signaling and the immune response ([@bib27], [@bib32], [@bib41]). So far, analysis of signaling during immune cell interactions has generally employed reductionist approaches; for example, cross-linking individual cell-surface proteins such as the T cell receptor (TCR) or co-stimulatory molecules with antibody ([@bib26], [@bib27], [@bib32], [@bib38]). Such approaches mimic the process of antigen-dependent stimulation that occurs when a T cell encounters antigen-presenting cells (APCs) expressing cognate peptide in the context of major histocompatibility complex (MHC) molecules. However, the unmet challenge is to globally map cellular signaling pathways activated when two cells physically interact, a more complex setting that recapitulates the uncharacterized complexity of receptor interactions that take place between immune cells and synergize to drive a cellular response.

To gain insight into the molecular mechanisms underlying HIV-1 spread between T cells, we developed an approach that employs triple SILAC (stable isotype labeling by amino acids in cell culture) with quantitative phosphoproteomics to map cellular signaling events simultaneously in two distinct cell populations. We have used this strategy to perform an unbiased and comprehensive analysis of how HIV-1 manipulates signaling when spreading between CD4 T cells. By simultaneously mapping real-time phosphorylation changes in HIV-1-infected and HIV-1-uninfected CD4 T cells with kinetic resolution, we identified the host cell pathways and cellular factors modified during HIV-1 dissemination. Remarkably, our results reveal that HIV-1 subverts canonical TCR signaling in the absence of antigen to drive spread at T cell-T cell contacts. Manipulation of T cell signaling by HIV-1 in this way represents a previously unknown strategy to promote efficient replication with important implications for disease pathogenesis.

Results {#sec2}
=======

Widespread Global Signaling Changes Induced during HIV-1 Spread between T Cells {#sec2.1}
-------------------------------------------------------------------------------

To obtain an unbiased and global overview of manipulation of host cell signaling during HIV-1 spread, we used SILAC coupled with quantitative phosphoproteomics analysis by MS. Jurkat CD4 T cells, a well-characterized model of HIV-1 infection and T cell signaling ([@bib1]), were labeled using either "heavy" (R10K8) or "light" (R0K0) amino acids for at least six doublings. SILAC-labeled R10K8 T cells were infected with HIV-1 by spinoculation to synchronize infection, achieving 90% infection after 48 hr ([Figure S1](#mmc1){ref-type="supplementary-material"}A). HIV-1-infected heavy- labeled and uninfected light-labeled target T cells were mixed to optimize contacts (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}) and either lysed immediately (0 min) or incubated at 37°C for 5, 20, or 40 min prior to lysis to allow for cell-cell contact and cross-talk ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). We expected rapid dynamics of cellular signaling and HIV-1 cell-cell spread during T cell-T cell contact ([@bib13], [@bib15], [@bib18]). To enable inter-time-point comparison and temporal analysis of dynamic signaling, each time point was supplemented post-lysis with an internal standard consisting of a pooled sample of mixed infected and uninfected T cells both labeled with "medium" (R6K4) amino acids and collected from each time point ([Figure 1](#fig1){ref-type="fig"}A). All samples were processed and analyzed by MS with quantification of abundance changes based on MS signal intensities of the triple-SILAC-labeled peptides. Raw MS data were processed using MaxQuant for protein assignment, quantification of peptides, phosphorylation, and phosphosite localization.

We identified a total of 28,853 phosphopeptides corresponding to 5,649 independent proteins ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B; [Table S1](#mmc2){ref-type="supplementary-material"}). This is the largest single dataset from a lymphocyte or hematopoietic cell analysis. We captured proteins across numerous subcellular localizations, including the cytoplasm (34.9%), nucleus (47.0%), and plasma membrane (6.2%), in both T cell populations ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Protein function analysis revealed a broad spectrum of host cell pathways modified in both infected and uninfected cells, demonstrating this approach yields an unbiased capture of the T cell phosphoproteome ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Phosphorylated serine and threonine were significantly more abundant than phosphorylated tyrosine (pS/pT/pY = 23,073:6,238:502), in agreement with their relative prevalence and key role in T cell signaling ([@bib27], [@bib31], [@bib38]).

Co-culturing HIV-1-infected (donor) and uninfected T cells (target) results in \>80% of uninfected target T cells becoming infected by contact-dependent cell-cell spread ([@bib25], [@bib49]). To determine the temporal changes in cellular signaling during HIV-1 spread from donor to target T cells, we curated the data to consider only high-confidence phosphorylation sites (phosphorylation score of \>0.75), proteins that were identified at all four time points (0, 5, 20, and 40 min) and those showing \>1.5-fold change in the abundance of phosphorylation compared to the internal medium-labeled reference ([Table S2](#mmc3){ref-type="supplementary-material"}). The relative abundance of phosphorylation states for all phosphosites was quantified and the change over time calculated ([Table S2](#mmc3){ref-type="supplementary-material"}). Statistically significant changes over time were detected in 938 phosphopeptides corresponding to 434 proteins in HIV-1 donor cells and 851 phosphopeptides corresponding to 430 proteins in target cells ([Figure S1](#mmc1){ref-type="supplementary-material"}A; [Tables S2-2](#mmc3){ref-type="supplementary-material"} and [S2-7](#mmc3){ref-type="supplementary-material"}). Consistent with rapid activation of signaling pathways, the largest changes in distribution and frequency of phosphopeptides from both cell populations were seen within the first 5 min ([Figures 1](#fig1){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}A--S2D). Temporal signaling changes defined groups of early- and late-responsive phosphosites and distinct clusters of responsive proteins, indicative of activation of specific cellular pathways in each cell population and downstream propagation of signaling cascades ([Figures 1](#fig1){ref-type="fig"}D, [S2](#mmc1){ref-type="supplementary-material"}E, and S2F). To confirm the data and obviate potential label bias, we repeated the experiment with reversed SILAC labeling. Phosphorylation changes were confirmed in 163 phosphopeptides corresponding to 134 proteins in the HIV-1 donor cell (134/434) ([Tables S2-4](#mmc3){ref-type="supplementary-material"} and [S2-5](#mmc3){ref-type="supplementary-material"}) and 141 phosphopeptides corresponding to 124 proteins in the target cell (124/430) ([Tables S2-9](#mmc3){ref-type="supplementary-material"} and [S2-10](#mmc3){ref-type="supplementary-material"}). This represents an average 29% overlap between replicate experiments ([Table S2](#mmc3){ref-type="supplementary-material"}; [Figure S3](#mmc1){ref-type="supplementary-material"}), in excellent agreement with the reproducibility of similar screens ([@bib32]). Of these, 108 phosphorylation sites were unique to infected cells ([Table S3-1](#mmc4){ref-type="supplementary-material"}), 86 phosphorylation sites were unique to the target cell ([Table S3-3](#mmc4){ref-type="supplementary-material"}), and 55 phosphorylation changes were common to both donors and targets ([Tables S3-2](#mmc4){ref-type="supplementary-material"} and [S3-4](#mmc4){ref-type="supplementary-material"}). This implicates specific host cell factors that may regulate the late steps of viral assembly and budding (donor cell specific), early infection effects (target cell specific) and common factors that may regulate T cell-T cell interactions and VS formation (overlapping).

Induction of T Cell Receptor Signaling in HIV-1-Infected Cells {#sec2.2}
--------------------------------------------------------------

We took an unbiased, Ingenuity Pathway Analysis (IPA) approach to analyze the host signaling networks and pathways modified during HIV-1 spread. This revealed that TCR signaling in donor T cells was the top canonical pathway modified over time during HIV-1 spread (TCR p value = 1.24 × 10^−12^). This was followed by CD28 (p value = 4.61 × 10^−11^), inducible T cell costimulator-inducible T cell costimulatory ligand (iCOS-iCOSL) (p value = 5.5 × 10^−9^), and actin cytoskeleton signaling (p value = 1.2 × 10^−8^) ([Figure 1](#fig1){ref-type="fig"}B; [Table S2](#mmc3){ref-type="supplementary-material"}). In uninfected target T cells, the top canonical pathways were TCR (p value = 5.39 × 10^−9^), CD28 (p value = 6.04 × 10^−7^), Cdc42 (p value = 8.73 × 10^−7^), RAC (p value = 1.02 × 10^−7^), and actin signaling (p value = 3.34 × 10^−7^) ([Figure 1](#fig1){ref-type="fig"}C; [Table S2](#mmc3){ref-type="supplementary-material"}). Motif-X analysis of phosphosites predicted the kinases most active in HIV-1 donor cells as CaMKII, PAK, and proline-directed kinases, compared to PAK, CDK5, and proline-directed kinases in target cells ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F).

The fact that TCR signaling was the most highly activated pathway in infected cells is surprising because HIV-1 mediated T cell-T cell contact during viral spread does not involve TCR-pMHC (peptide major histocompatibility complex) interactions and as such is antigen-independent. Rather it is driven by Env expressed in infected cells engaging viral entry receptors (CD4 and CCR5 or CXCR4) on opposing cells during T cell-T cell interactions with additional contributions from adhesion molecules (LFA-1 and ICAM) ([@bib8], [@bib18], [@bib19], [@bib37], [@bib49]). [Figure 2](#fig2){ref-type="fig"}A graphically summarizes the phosphoproteins we identified in HIV-1 donor cells mapped onto signaling pathways associated with canonical T cell activation at T cell-APC contacts. This visual representation highlights the significant overlap between the well-established TCR/co-stimulatory signaling pathway and phosphorylation changes identified in HIV-1 donor cells during contact with targets.

To explore this further, we compared our phosphoproteome data with studies where the TCR was directly cross-linked on Jurkat T cells, and signaling was analyzed across similar time points. We found a 44% overlap between the phosphorylation profile of HIV-1 donor cells during co-culture with target cells and TCR-specific responses reported by Chylek et al. ([@bib9]) and a 30% overlap with Mayya et al. ([@bib27]) ([Figure 2](#fig2){ref-type="fig"}B; [Table S4-2](#mmc5){ref-type="supplementary-material"}). KEGG database analysis also reported substantial overlap between our phosphoproteome results and phosphorylation of TCR-associated proteins ([Table S4-1](#mmc5){ref-type="supplementary-material"}).

Interestingly, we identified multiple proteins in our data with phosphorylation changes that mapped to early plasma membrane proximal (CD3, Lck, CD43, CD2AP, GADS, and talin) and intermediate/late components of TCR signaling, as well as downstream regulators of gene expression (ERK1/2, AKT, ETS1, and NFAT) ([Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}). Many of the residues modified were known activating sites ([Tables S2-5](#mmc3){ref-type="supplementary-material"} and [S2-10](#mmc3){ref-type="supplementary-material"}). T cell signaling modulates the host cell cytoskeleton and the protein trafficking that is required for T cell activation and secretion of effector molecules ([@bib6], [@bib12]). Consistent with the notion that HIV-1 cell-cell spread is an active, cytoskeletal-dependent process and that virus infection drives this process ([@bib18]), we found dynamic phosphorylation changes to many actin regulators (PAK1, CFL, PALLD, MYH10, VIM, and WAS), polarity proteins (SCRIB) and components of vesicle trafficking and fusion (SNAP23) ([Table S2](#mmc3){ref-type="supplementary-material"}), most of which that have not been previously described as host cofactors for HIV-1 replication and spread.

HIV-1 predominantly spreads at virus-induced cell-cell contacts but can also disseminate less efficiently via classical diffusion-limited cell-free infection. Comparative analysis of our results obtained from target T cells with a study mapping phosphorylation in T cells exposed to cell-free virus ([@bib55]) showed a 23% overlap in modified proteins, with 41% of the phosphorylation changes in these proteins mapping to the same site ([Table S5](#mmc6){ref-type="supplementary-material"}). Since the molecular processes of HIV-1 entry and the early steps of infection are similar between cell-free and cell-cell spread ([@bib18], [@bib17]), some overlap is expected; however, differences implicate additional signaling pathways specifically activated during T cell-T cell contact and other unique responses occurring when target cells encounter greater numbers of incoming virions during cell-cell spread ([@bib18], [@bib25], [@bib49]).

TCR Signaling by a Non-canonical Means Employs Classical T Cell Kinases {#sec2.3}
-----------------------------------------------------------------------

Having identified changes in phosphorylation of key components of classical T cell signaling during HIV-1 spread, which strongly indicates activation, we sought to validate this observation directly using western blotting to visualize protein phosphorylation and quantified this from multiple experiments using densitometry analysis ([Figures 3](#fig3){ref-type="fig"}, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"}). Proteins were chosen that represented upstream kinases, cytoskeletal proteins, and transcriptional regulators involved in T cell receptor signaling that showed dynamic phosphorylation changes at defined sites that dictate protein function (e.g., Lck^Y394^, PAK1^S204^, CFL^S3^, ERK^T202/Y204^, AKT^T308^, and AKT^S473^). Other components of the top canonical pathways activated (e.g., ZAP70^Y319^ and LAT^Y191^) were also included. [Figures 3](#fig3){ref-type="fig"}A and 3B shows that contact between HIV-1-infected and HIV-1-uninfected T cells increased phosphorylation of the actin regulators PAK1^S204^ and CFL^S3^. While PAK1 activation was specific to contacts mediated by HIV-1-infected cells, CFL phosphorylation appeared to be infection-independent and was also triggered by contact between uninfected T cells ([Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}). However, as T cells do not usually form sustained cell-cell contacts in the absence of retroviral infection ([@bib17]) or previous antigenic stimulation ([@bib39]), this may be unlikely to occur under normal conditions of transient cell interactions. PAK1 influences cytoskeletal dynamics and T cell activation and is activated through phosphorylation at Ser204 via TCR-dependent ([@bib57]) and TCR-independent mechanisms ([@bib36]). CFL, a downstream target of the PAK1 cascade, stimulates actin severance and depolymerization to increase actin turnover and is inactivated by LIMK phosphorylation at Ser3 ([@bib58]), potentially stabilizing cell-cell contacts. Modulation of cytoskeletal dynamics is thus consistent with the requirement for actin remodeling during immune cell interactions and HIV-1 cell-cell spread ([@bib18], [@bib20], [@bib37]). Next, we examined Lck and ZAP70 ([Figures 3](#fig3){ref-type="fig"}C, 3D, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"}), which are TCR-proximal kinases and key initiators of T cell signaling ([@bib6], [@bib16]). Lck activity is regulated by multiple phosphorylation states (activating site Lck^Y394^; inhibitory site Lck^Y505^) and intracellular localization ([@bib7], [@bib33], [@bib40]). ZAP70 activity is positively regulated by Y319 phosphorylation ([@bib11]). Consistent with activation of TCR signaling, rapid and dynamic changes to both Lck^Y394^ and ZAP70^Y319^ were seen over time during HIV-1-induced cell-cell contact ([Figures 3](#fig3){ref-type="fig"}C, 3D, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"}), with identical patterns of phosphorylation indicative of Lck-dependent ZAP70 activation ([@bib6]). A slight dip in Lck and ZAP70 phosphorylation was seen at 20 min, although the reasons for this are unclear. By contrast, activation of LAT^Y191^ was unchanged in both MS and western blotting ([Figures 3](#fig3){ref-type="fig"}E, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"}; [Table S1](#mmc2){ref-type="supplementary-material"}). Supporting our phosphoproteome data showing downstream propagation of signaling cascades ([Figure 2](#fig2){ref-type="fig"}), strong activation of ERK^T202/Y204^ during HIV-mediated cell-cell contact was observed by 40 min ([Figures 3](#fig3){ref-type="fig"}F, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"}). Finally, having found phosphorylation of the serine/threonine kinase AKT and a number of downstream targets by MS (e.g., TSC1, TBS1D4, PTPN1, Girdin, GSK3β, and HTT; [Table S2](#mmc3){ref-type="supplementary-material"}), we tested phosphorylation of AKT^T308^ and AKT^S473^. AKT^T308^, which lies in the activation loop of AKT and is most correlative with kinase activity ([@bib3]), showed a 1.5-fold increase in phosphorylation during HIV-1-mediated cell-cell contact ([Figures 3](#fig3){ref-type="fig"}G, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"}). By contrast, AKT^S473^ that contributes to further kinase function ([@bib42]), and phosphorylation of additional downstream targets appeared to be activated by cell-cell contact independent of HIV-1 infection ([Figures 3](#fig3){ref-type="fig"}G, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"}).

Next, we extended the analyses to primary CD4 T cells purified from healthy donors that were infected with HIV-1 ex vivo and mixed with autologous CD4 T cells ([Figures 3](#fig3){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}) as well as mock-infected controls ([Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}). Primary T cells showed similar patterns of HIV-dependent, contact-mediated phosphorylation over time but more rapid propagation of signaling and more robust AKT^T308^ activation ([Figures 3](#fig3){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}), in agreement with previous data indicating HIV-1-infected primary T cells are highly responsive to contact with target cells ([@bib13]). However, western blotting of total cell lysates from primary cells did not reveal global changes in Lck phosphorylation ([Figures 3](#fig3){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}), consistent with high basal levels of Lck phosphorylation in primary T cells ([@bib33]).

The T Cell Receptor Is Required for Efficient HIV-1 Spread at T Cell Contacts {#sec2.4}
-----------------------------------------------------------------------------

Signaling through the TCR is considered a tightly controlled checkpoint to ensure T cell activation only occurs in response to foreign antigen displayed by MHC. It is therefore striking that antigen-independent, HIV-1-induced T cell-T cell interactions should trigger classical TCR signaling cascades and phosphorylation of numerous pathway components. To probe the relationship between the TCR complex and contact-induced activation of signaling in HIV-1 donor cells, TCR/CD3-negative T cells were infected with HIV-1 and phosphorylation examined. Notably, HIV-1-infected TCR-negative cells did not phosphorylate PAK, Lck, ZAP70, or ERK in response to contact with target T cells ([Figures 3](#fig3){ref-type="fig"}A, 3C, 3D, 3F, and [S5](#mmc1){ref-type="supplementary-material"}), implicating the TCR in signal activation. As a control, we confirmed TCR-negative cells retained expression of Lck ([Figure S4](#mmc1){ref-type="supplementary-material"}L) and that HIV-1-infected cells did not downregulate cell-surface expression of the TCR/CD3 complex ([Figures S4](#mmc1){ref-type="supplementary-material"}J and S4K).

Seeking a role for TCR-dependent signaling in HIV-1 spread, TCR-negative cells were infected and their ability to support viral replication measured. TCR-negative cells were readily susceptible to initial infection with HIV-1 ([Figure 3](#fig3){ref-type="fig"}I) and showed no defect in cell-free virus production over a single round of infection, as measured by quantifying release of viral Gag (budding) and particle infectivity ([Figures 3](#fig3){ref-type="fig"}J and 3K). Remarkably, when infected cells were incubated with wild-type target T cells, we observed a significant defect in their ability to transmit virus by cell-cell spread ([Figure 3](#fig3){ref-type="fig"}L). Reconstituting TCR expression using lentiviral transduction resulted in \>85% of cells expressing the TCR complex at the cell surface ([Figure S4](#mmc1){ref-type="supplementary-material"}I) and rescued HIV-1 cell-cell spread ([Figure 3](#fig3){ref-type="fig"}M). Failure of TCR-negative cells to efficiently transmit virus by cell-cell spread indicates an important role for the TCR in VS formation and virus spread. Quantitative immunofluorescence microscopy ([Figure 3](#fig3){ref-type="fig"}N) revealed TCR-negative cells were indeed impaired in VS formation and could not recruit the viral structural proteins Gag and Env to sites of cell-cell contact to polarize viral budding toward the target cell (Env enrichment at contact site: wild-type (WT), 10-fold ± 2.6-fold, n = 17; TCR negative, 1.6-fold ± 0.5-fold, n = 16; Gag enrichment at contact site: WT, 18.3-fold ± 5.7-fold, n = 14; TCR negative, 1.7-fold ± 0.3-fold, n = 16).

We hypothesized that close and sustained contact between infected and uninfected cells may be inducing TCR coalescence at the contact site as a mechanism of receptor triggering ([@bib53]). In support of this model, analysis of contacts formed between HIV-1-infected primary T cells and autologous uninfected T cells showed that 70% of VSs displayed co-enrichment of the TCR and Env on infected cells at the contact zone ([Figures 3](#fig3){ref-type="fig"}O and 3P), despite the absence of direct antigen-dependent TCR engagement by opposing uninfected targets. Quantification of fluorescence revealed the TCR was enriched 3.3-fold ± 0.6-fold and Env 6.9-fold ± 1.5-fold at the contact site (n = 20).

Lck and ZAP70 Support HIV-1 Spread between T Cells {#sec2.5}
--------------------------------------------------

The kinase Lck is a key upstream initiator of TCR signaling and activation of cytoskeletal dynamics at immune cell contacts ([@bib10], [@bib16], [@bib23], [@bib33], [@bib50]). To test whether signaling during HIV-1-induced T cell contact was Lck dependent, Lck-negative JCAM1.6 cells were infected with virus and mixed with wild-type target T cells, and protein phosphorylation was analyzed. [Figures 4](#fig4){ref-type="fig"}A--4G and quantification of western blots ([Figure S5](#mmc1){ref-type="supplementary-material"}) revealed that Lck-negative HIV-1-infected cells were unable to initiate signaling and activate PAK1^S204^, ZAP70^Y319^, ERK^T202/Y204^, and AKT^T308^, whereas CFL remained responsive. To examine whether Lck and the downstream kinase ZAP70 contribute functionally to HIV-1 replication, Lck- and ZAP70-negative T cells were infected, and virus assembly, budding, and spread were quantified. We used VSV-G-pseudotyped virus to overcome variable expression of the receptor CD4. Notably, both Lck- and ZAP70-negative Jurkat cells failed to support efficient cell-cell spread ([Figure 4](#fig4){ref-type="fig"}L). In agreement with data using TCR-defective cells, impaired cell-cell spread in Lck- and ZAP70-deficient Jurkat cells was not due to a block in virus infection or a defect in virus production, since the cell-free virus budding and particle infectivity were equivalent to that of WT Jurkat cells ([Figures 4](#fig4){ref-type="fig"}I and 4K). However, as expected, there was a significant defect in VS formation and failure to recruit Env and Gag to the contact interface ([Figures 4](#fig4){ref-type="fig"}M and 4N) but no effect on cell-cell contact (WT, 27%; Lck negative, 20%; and ZAP70 negative, 19%; p \> 0.05), demonstrating that Lck and ZAP70 are not mediating their effect through altering T cell-T cell interactions. Reconstituting cells with exogenous Lck and ZAP70 ([Figures S4](#mmc1){ref-type="supplementary-material"}M and S4N) significantly increased cell-cell spread ([Figure 4](#fig4){ref-type="fig"}l) and restored VS formation ([Figure 4](#fig4){ref-type="fig"}O) as measured by Env and Gag recruitment to the cell-cell interface (Env enrichment at contact site: Lck negative, 2.6-fold ± 1.5-fold, n = 15; Lck reconstituted, 9.5-fold ± 4.5-fold, n = 15; ZAP70 negative, 3.1-fold ± 1.2-fold, n = 14; ZAP70 reconstituted, 10.7-fold ± 3.6-fold, n = 12; Gag enrichment at contact site: Lck negative, 1.9-fold ± 0.8-fold, n = 15; Lck reconstituted, 5.6-fold ± 1.8-fold, n = 17; ZAP70 negative, 2.4-fold ± 0.7-fold, n = 16; ZAP70 reconstituted, 14.5-fold ± 6.6-fold, n = 12).

Viral Determinants of Contact-Induced T Cell Signaling {#sec2.6}
------------------------------------------------------

The viral determinants of contact-induced antigen-independent T cell signaling remained unclear. HIV-1 Env expressed on the surface of infected T cells binds cellular entry receptors on opposing cells, leading to sustained cell-cell contact, plasma membrane remodeling, receptor clustering, and VS formation ([@bib18]). Consistent with antigen-independent T cell signaling being driven by close, sustained physical cell contact mediated by Env-CD4/coreceptor interactions, T cells infected with Env-deleted VSV-G-pseudotyped virus (HIV+ ΔEnv) did not activate phosphorylation of T cell signaling components following incubation with target cells, with the exception of CFL and AKT^473^ ([Figures 5](#fig5){ref-type="fig"}A--5F and [S5](#mmc1){ref-type="supplementary-material"}). Similar results were observed when primary CD4 T cells were infected with ΔEnv VSV-G-pseudotyped virus ([Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}). We postulated that failure to activate signaling was because TCR clustering did not occur in the absence of HIV-1 Env-mediated cell-cell contact. Concordantly, we observed a significant reduction in the number of cell-cell contacts displaying TCR clustering in the absence of HIV-1 Env expression on infected primary CD4 T cells ([Figure 5](#fig5){ref-type="fig"}I), with only 16% of contacts showing TCR enrichment when cells were infected with HIV ΔEnv virus compared to 70% using WT virus (p \< 0.001).

The HIV-1 accessory protein Nef has been reported to modulate T cell signaling ([@bib35], [@bib47]) and induce hyper-responsiveness to stimulation ([@bib14], [@bib44], [@bib54]). To test whether Nef was potentiating antigen-independent signaling, T cells were infected with Nef-deleted virus and signaling examined. [Figures 5](#fig5){ref-type="fig"}A--5G shows that deletion of Nef resulted in failure to activate ERK^T202/Y204^, Lck^Y394^, ZAP70^Y319^, and PAK1^S204^ following incubation with target cells, with AKT^T308^ phosphorylation remaining responsive to cell-cell contact ([Figures 5](#fig5){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}). However, in contrast to Env, Nef appeared dispensable for TCR clustering at the VS ([Figure 5](#fig5){ref-type="fig"}I), suggesting Nef potentiation of signaling acts downstream of cell-cell contact. Taken together, these data demonstrate HIV-1 infection induces antigen-independent TCR signaling that is activated by Env-dependent cell-cell contact and further potentiated by the HIV-1 virulence factor Nef.

Discussion {#sec3}
==========

Here, we have developed an approach to globally map phosphorylation-based dynamic signaling events in complex mixed cell populations and performed an analysis of host cell signaling pathways that are manipulated during HIV-1 spread between CD4 T cells. Cell-cell spread of HIV-1 potently enhances viral dissemination ([@bib15], [@bib20], [@bib25], [@bib49]), but many aspects of this host-pathogen interaction remain obscure. Our identification of \>200 host cell factors that are manipulated during highly efficient HIV-1 spread is thus timely and provides a wealth of information with implications for pathogenesis. Furthermore, the experimental approach we describe has broad applicability and can be readily applied to complex biological analyses such as signaling during intercellular communication or to define host cell responses to the sequential steps of pathogen replication.

Notably, we make the unexpected discovery that HIV-1 subverts classical TCR signaling pathways independently of antigen during cell-cell contact to drive viral spread from infected to uninfected T cells. Specifically, we found that cell-cell contact mediated by Env uniquely activates the TCR/CD3 complex and downstream kinases Lck and ZAP70 in infected T cells and that this process is required to transmit virus to neighboring cells. We propose a paradigm (model) of TCR signaling ([Figure 5](#fig5){ref-type="fig"}J) in which the close apposition and sustained physical contact between HIV-1-infected and -uninfected T cells, which are mediated by Env-receptor interactions and remodel the synaptic plasma membrane, lead to aggregation and enrichment of the TCR/CD3 complex at the contact site and initiation of TCR signaling. Specifically, the presence of plasma-membrane-exposed Env engaging CD4 and coreceptor on target cells results in coalescence and enrichment of cross-linked Env at the VS ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) ([@bib18]). Concomitantly, we observe Env-dependent clustering of TCR-containing plasma membrane microdomains at the cell-cell interface ([Figures 3](#fig3){ref-type="fig"} and [5](#fig5){ref-type="fig"}) and activation of Lck-dependent signaling. We propose that activating signaling could then drive the recruitment of additional Env and Gag to the contact zone as we found here by quantifying viral protein enrichment (potentially via cytoskeletal remodeling and activation of intracellular transport pathways), resulting in polarized HIV-1 assembly and budding of virions across the synaptic space toward the engaged target cell. The TCR, Lck and ZAP70 comprise a triad of early T cell signaling initiators that trigger cytoskeletal remodeling and intracellular trafficking. Consistent with this, these host proteins were all required to direct the active transport of HIV-1 structural proteins Env and Gag to sites of cell-cell contact. In support of our results, ZAP70 has previously been implicated in HIV-1 spread and VS formation ([@bib48]). While our data reveal a compelling role for antigen-independent TCR triggering for synaptic signaling, VS formation, and rapid HIV-1 transmission, we cannot discount the contribution of other cell-surface receptors, such as LFA-1 (which is recruited to both the immunological and virological synapses) or indeed other as-yet-unidentified pathways, in contact-induced signaling during HIV-1 spread. Unfortunately, ablation of LFA-1 expression significantly impaired the stability of cell-cell contacts (data not shown), meaning we were unable to assess the contribution of adhesion molecules to signaling. Future work will undoubtedly be informative to further define these processes.

Jurkat cells have been used extensively to interrogate T cell signaling and HIV-1 cell-cell spread; however, they are constitutively activated and can lack components of the T cell signaling machinery. For example, PTEN deficiency results in higher levels of basal AKT activation in transformed cell lines, including Jurkats ([@bib56]). This is reflected in our results, where we detected more robust contact-dependent AKT^T308^ phosphorylation in primary T cells compared to Jurkat cells. By contrast, primary T cells show high basal Lck activation ([@bib33]), making it difficult to detect differential Lck phosphorylation by western blotting, as we also observed. However, having performed experiments using both Jurkats and primary T cells, we provide compelling data attesting to contact-mediated activation of T cell signaling that is dependent on HIV-1 infection and Env expression. This was supported by our observation that the TCR complex is recruited to the VS formed between primary T cells in an Env-dependent manner. Furthermore, cell lines lacking the TCR or Lck were unable to activate signaling, form VSs, and drive viral spread. That we were previously unable to detect significant enrichment of CD3 at the VS in an earlier study using T cell lines ([@bib18]) is likely to due to suboptimal staining conditions and the choice of cells in that study. Here, we find that cell permeabilization prior to staining with commercial antibody and the use of primary CD4 T cells greatly improved the intensity of CD3 staining and revealed robust and reproducible enrichment of TCR/CD3 at the VS.

Our simultaneous analysis of phosphorylation changes in HIV-1-infected and HIV-1-uninfected T cells during viral dissemination revealed widespread modulation of host cell pathways by HIV-1 that support viral replication by activating unique replication-enhancing signals. In addition to the requirement for physical cell-cell contact mediated by Env, the viral accessory protein Nef was necessary, but not sufficient, for contact-induced TCR signaling. Nef is multifunctional modulator of T cell signaling ([@bib4]) that has been implicated in aberrant Lck activation independent of the TCR during T cell-APC interactions and perturbation of immune synapse formation ([@bib35], [@bib51]). However, conflicting reports about Nef's ability to potentiate or suppress signaling means the biological consequences for viral spread remain poorly understood. Intriguingly, the Nef proteins of HIV-1 and its ancestor, SIV~cpz~, unlike most other simian immunodeficiency viruses (SIVs), do not downregulate expression of the TCR on infected T cells ([@bib5], [@bib43]). Why HIV-1 does not employ this potential immune-evasion strategy has remained enigmatic. We propose that HIV-1 has instead evolved to preserve expression and exploit the TCR through molecular reprogramming of classical T cell signaling pathways during cell-cell contact, allowing for optimal viral replication and spread between human CD4 T cells. That most SIVs downregulate the TCR on infected cells raises the intriguing question of how those viruses disseminate between cells. Whether they exploit an alternate mechanism for driving spread between T cells in contact, and if this contributes to differences in immune activation and disease pathogenesis seen in natural SIV infections ([@bib22]), is unknown. Future studies to address this would be extremely interesting and undoubtedly shed new light on unresolved questions surrounding the pathogenicity of lentiviral infection.

We envisage that the insights our data provide into the manipulation of T cell signaling by HIV-1, coupled with the identification of \>200 host cell factors modified during viral spread, will inform future studies aimed at defining the molecular processes regulating successful HIV-1 replication in both infected and susceptible target T cells and the associated immunological dysfunction causing AIDS. In an era in which ex vivo manipulation of T cells is increasingly deployed for diverse immunotherapy strategies, our findings have clear importance beyond the sphere of HIV-1 and define concepts of T cell activation that could be considered in future immunomodulatory strategies.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

Jurkat T cell lines and HeLa TZM-bl and 293T cells were cultured, infected, or transduced as described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Primary CD4 T cells were isolated from peripheral blood of healthy donors by Ficoll gradient centrifugation and negative selection (Miltenyi Biotec), cultured, and infected as described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Virus Production and Infection {#sec4.2}
------------------------------

HIV-1 was prepared from the molecular clone pNL4.3 (NIH AIDS Reagent and Reference Program \[ARRP\]) by transfecting 293T cells using Fugene 6 (Promega) and infectious virus titered on HeLa TZM-bl cells using Bright-Glo Luciferase assay (Promega). Jurkat cells or primary CD4 T cells were infected with HIV-1 NL4.3 by spinoculation ([@bib13]) and incubated for 48 hr prior to use. Alternatively, cells were infected with VSV-G-pseudotyped virus generated by transfecting 293T cells with pNL4.3, pNL4.3 ΔNef, or pNL4.3 ΔEnv and pMDG ([@bib30]). Infection was quantified by flow cytometry staining for intracellular Gag ([@bib13]).

Quantitative Phosphoproteomics and Mass Spectrometry Analysis {#sec4.3}
-------------------------------------------------------------

Triple SILAC was performed on Jurkat CE6-1 cells and incorporation confirmed by MS. Jurkat cells labeled with heavy (R10K8) amino acids were infected with HIV-1 and mixed with uninfected target Jurkat cells labeled with light (R0K0) amino acids. Medium-labeled (R6K4) cells were used as an internal reference. Infected and uninfected T cells were mixed and incubated for 0, 5, 20, or 40 min prior to lysis. All time-point samples were buffer exchanged, reduced, and alkylated and subsequently digested using filter aided sample preparation (FASP). Digested peptides were fractionated via hydrophilic interaction chromatography (HILIC) and enriched for phosphopeptides using titanium immobilized metal affinity chromatography (Ti-IMAC) and analyzed by high-resolution nano-liquid chromatography electrospray ionization (nano-LC ESI) MS/MS. Raw MS data were processed using MaxQuant for protein assignment, quantification of peptides, phosphorylation, and phosphosite localization. Refer to [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for more information.

SDS-PAGE and Western Blotting {#sec4.4}
-----------------------------

Cell lysates were prepared as described for MS. Proteins from an equal number of cells were separated by SDS-PAGE, transferred to nitrocellulose, and subjected to western blotting for total and phosphorylated proteins as described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Blots are representative of two or three independent experiments. Densitometry quantification of bands was performed using ImageJ. The band intensity for each phosphoprotein was normalized to the corresponding total protein at each time point and plotted as the mean fold change in protein phosphorylation (where t = 0 min was normalized to 1) from multiple experiments.

HIV-1 Replication Assays {#sec4.5}
------------------------

Jurkat T cells were infected with VSV-G-pseudotyped HIV-1. Forty-eight hr post-infection, viral supernatants were harvested and Gagp24 quantified by ELISA ([@bib20]). Virion infectivity was determined by luciferase assay using HeLa TZM-bl reporter cells. HIV-1 cell-cell spread was measured by quantitative real-time PCR ([@bib20], [@bib25]), and data are shown as the fold increase in HIV-1 DNA compared to the albumin housekeeping gene and normalized to baseline (0 hr), reflecting de novo reverse transcription in newly infected target T cells during cell-cell spread. Alternatively, Jurkat 1G5 target T cells containing a luciferase reporter gene driven by the HIV-1 long terminal repeat (LTR) were used and cell-cell spread measured by luminescence assay ([@bib13]).

Immunofluorescence Microscopy {#sec4.6}
-----------------------------

Quantification of T cell-T cell contacts and VS was performed as described previously ([@bib18]). Conjugates were defined as two closely apposed cells consisting of one HIV-1-infected T cell and one target T cell. VSs were defined as conjugates showing enrichment of HIV-1 Env and Gag to the site of cell-cell contact ([@bib18], [@bib37]). Images were acquired using the DeltaVision ELITE Image Restoration Microscope (Applied Precision) coupled to an inverted Olympus IX71 microscope and a CoolSNAP HQ2 camera, deconvolved with softWoRx 5.0 and processed using Huygens Professional v4.0 and Adobe Photoshop C3. Quantification of fluorescence intensity was performed using ImageJ. A region of interest at the contact site (ROI 1) was selected and compared to a region on the opposite side of the cell (ROI 2). The integrated density was adjusted for the size of region of interest and for background, and the fold enrichment of fluorescence signal at the contact zone was determined for at least 20 contacts from two independent experiments.

Statistical Analysis {#sec4.7}
--------------------

Statistical significance was calculated using the Student's t test or the Mann-Whitney test. For multiple comparisons, statistical significance was calculated using the parametric ANOVA test with Bonferroni correction. Significance was assumed when p \< 0.05. All tests were carried out in GraphPad Prism 6 software.
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![Summary of Phosphoproteome Data\
(A) Schematic representation of the screen, work flow, and analysis.\
(B) Top canonical pathways modified in the HIV-1-infected donor T cell from Ingenuity Pathway Analysis (IPA) of experiment 1. Magenta circles indicate proteins with differentially phosphorylated phosphosites (\>1.5-fold over time). Blue circles indicate proteins that were identified, but not differentially phosphorylated, in our study. Size of circles represents the magnitude of phosphorylation change.\
(C) Top canonical pathways modified in the target T cell from IPA.\
(D) Heatmap depicting quantified phosphorylation sites that demonstrated change in phosphorylation over time from experiment 1. Yellow color denotes increased phosphorylation and blue decreased phosphorylation. Heatmaps were generated using GProX.\
See also [Figures S1--S3](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, and [S3](#mmc4){ref-type="supplementary-material"}.](gr1){#fig1}

![HIV-1-Infected T Cells Show Activation of Immune Receptor Signaling Pathways following Cell-Cell Contact\
(A) Summary diagram of the TCR, CD28, and iCOS-iCOSL signaling pathways adapted from IPA. Proteins names in red text were identified in our study to be differentially phosphorylated in HIV-1-infected cells in response to cell-cell contact (refer to [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}). For each phosphorylated protein, the specific phosphosite modified is indicated with adjacent red text (e.g., Y187, Y202, and Y204 for ERK). Proteins named in black text map to the TCR, CD28, and iCOS-ICOSL pathways but were either not identified in our study or did not show phosphorylation changes. Colored outlines and shapes of proteins denote protein function (e.g., TCR/CD3, immune receptor, phosphatase, kinase, transcription factor, small molecule, and other).\
(B) Overlap between phosphosites identified in our study mapping to top canonical pathways modified in HIV-1-infected cells (refer to [Table S2](#mmc3){ref-type="supplementary-material"}) and those identified as TCR responsive by Mayya et al. ([@bib27]) and Chylek et al. ([@bib9]).\
See also [Table S4](#mmc5){ref-type="supplementary-material"}.](gr2){#fig2}

![T Cell Receptor Signaling Drives HIV-1 Cell-Cell Spread\
(A--H) Protein phosphorylation analysis by western blotting of lysates prepared from contacts between infected and uninfected T cells. Blots are representative of at least two independent experiments. Antibodies specific for phosphorylated and total protein were used (A--G). HIV-1 Gag p55 confirms infection and equal loading (H). The left panels show HIV-1 infected Jurkat T cells and uninfected Jurkat targets. The middle panels show HIV-1-infected primary CD4 T cells and uninfected primary CD4 targets. The right panels show HIV-1 infected TCR-negative Jurkat T cells and uninfected WT Jurkat targets.\
(I--L) Jurkat T cells were infected with VSV-G pseudotyped HIV-1. (I) Infected cells were quantified by flow cytometry. (J) Virus budding was measured by Gag p24 ELISA. (K) Virion infectivity was measured by luciferase assay. (L) Quantification of cell-cell spread by real-time qPCR. Values show the fold-increase in viral DNA over time compared to the baseline (0 hr), reflecting de novo reverse transcription in newly infected target cells.\
(M) Quantification of cell-cell spread from infected WT, TCR-negative, and TCR-reconstituted cells measured by luciferase assay (RLU, relative light units).\
(N) HIV-1-infected TCR-negative cells form fewer VSs (number of cell-cell contacts analyzed: WT, n = 29; TCR negative, n = 32).\
(O) The TCR complex component CD3 is co-polarized with HIV-1 Env at the interface formed between HIV-1-infected primary T cells (bottom, asterisk) and autologous target T cells (top). Scale bar, 5 μm.\
(P) Quantification of the frequency of CD3 enrichment at the contact zone (number of cell-cell contacts analyzed: donor A, n = 41; donor B, n = 13).\
Data represent mean ± SEM from two or three independent experiments. ^∗∗^p \< 0.005; ^∗∗∗^p \< 0.001. See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![T Cell Kinases Lck and ZAP70 Are Required for Efficient HIV-1 Spread\
(A--H) Protein phosphorylation analysis by western blotting of lysates (A--G) (see [Figure 3](#fig3){ref-type="fig"}) prepared from contacts between HIV-1 infected Lck-negative Jurkat T cells and uninfected wild-type Jurkat targets. Blots are representative of at least two independent experiments.\
(I) Quantification of infection by flow cytometry.\
(J) Quantification of cell-free virus budding by Gag p24 ELISA.\
(K) Particle infectivity determined by reporter cell luciferase assay.\
(L) Quantification of HIV-1 cell-cell spread from infected Jurkat T cells by real-time qPCR.\
(M) Percentage of infected Jurkat (Gag, green; Env, red) and uninfected target cells (dye-labeled, blue) contacts showing polarization of Env and Gag to the contact zone (percentage of virological synapses \[VSs\]) (number of cell-cell contacts analyzed: WT, n = 30; Lck negative, n = 30; ZAP70 negative, n = 30).\
(N) Representative images of normal VSs (WT) and defective VSs (Lck and ZAP70 negative) formed between an HIV-1-infected Jurkat T cell (bottom, asterisk) and an uninfected target T cell (top).\
(O) Reconstituting Lck and ZAP70 expression restores VS formation (number of cell-cell contacts analyzed: WT, n = 59; Lck negative, n = 58; Lck positive, n = 48; ZAP70 negative, n = 60; ZAP70 positive, n = 38).\
Data represent mean ± SEM from three independent experiments. ^∗∗^p \< 0.005; ^∗∗∗^p \< 0.001. See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Viral Determinants of Contact-Induced TCR Signaling\
(A--H) Protein phosphorylation was determined by western blotting (A--G) (see [Figure 3](#fig3){ref-type="fig"}). Blots are representative of at least two independent experiments. The left panels show Jurkat T cells infected with VSV-G-pseudotyped HIV-1 containing a frameshift mutation in Env (ΔEnv) and incubated with uninfected target cells. The right panels show Jurkat T cells infected with VSV-G-pseudotyped ΔNef HIV-1 and incubated with uninfected target cells.\
(I) Quantification of the frequency of CD3 enrichment at the contact zone using viral mutants (black filled, percentage of CD3-enriched contacts; gray filled, percentage of CD3-nonenriched contacts) (number of cell-cell contacts analyzed: WT, n = 54; ΔEnv, n = 31; ΔNef, n = 30). Data from two independent primary T cell donors with the SEM.\
(J) Model depicting contact-induced activation of TCR signaling during HIV-1 cell-cell spread.\
See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}
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